Skip to main content
. 2019 Nov 22;10:820. doi: 10.3389/fendo.2019.00820

Figure 5.

Figure 5

Decrease in eGFR over 40%-free survival rates in the patients with diabetes. The outcome was estimated using Cox regression models stratified according to history of eGFR decrease over 40% for SGLT2 inhibitor users vs. non-users. eGFR, estimated glomerular filtration rate; SGLT2i, sodium–glucose cotransporter 2 inhibitor.